459Wire StoriesThe 4th Dahua Partner Day Held in Paris
HANGZHOU, China–(BUSINESS WIRE)–#AI–Dahua Technology, a world-leading video-centric smart IoT solution and service provider, hosted the 4th Dahua Partner Day at Versailles Palais...
- 437Wire Stories
ChromaDex’s Tru Niagen® Won the “Most Popular Brand of the Year Award” at China International Natural Health & Nutrition Expo’s (NHNE) Prestigious Nutrition Planet Awards
Tru Niagen® was recognized for its industry-leading research, increased presence on cross-border e-commerce channels, and high engagement on several social media platforms...
- 467Wire Stories
ChromaDex’s Tru Niagen® Won the “Most Popular Brand of the Year Award” at China International Natural Health & Nutrition Expo’s (NHNE) Prestigious Nutrition Planet Awards
Tru Niagen® was recognized for its industry-leading research, increased presence on cross-border e-commerce channels, and high engagement on several social media platforms...
- 472Wire Stories
IperionX Sustainability Report – 2022
CHARLOTTE, N.C.–(BUSINESS WIRE)–$IPX #3Dprinting—IperionX Limited (“IperionX” or “Company”) (Nasdaq: IPX, ASX: IPX) is pleased to release the Company’s inaugural Sustainability Report, which...
- 472Wire Stories
Quizartinib Granted Priority Review in the U.S. for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia
Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone TOKYO & BASKING RIDGE, N.J.–(BUSINESS...
- 497Wire Stories
IperionX Sustainability Report – 2022
CHARLOTTE, N.C.–(BUSINESS WIRE)–$IPX #3Dprinting—IperionX Limited (“IperionX” or “Company”) (Nasdaq: IPX, ASX: IPX) is pleased to release the Company’s inaugural Sustainability Report, which...
- 492Wire Stories
Quizartinib Granted Priority Review in the U.S. for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia
Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone TOKYO & BASKING RIDGE, N.J.–(BUSINESS...
- 664Wire Stories
Kyriba Revolutionizes Cash Forecasting for CFOs with Liquidity Planning Platform
New Solution Helps Predict and Reach Free Cash Flow Targets to Improve Financial Resilience Against Market Volatility SAN DIEGO–(BUSINESS WIRE)–#API—Kyriba, (“the Company”),...
- 528Wire Stories
Fortis Life Sciences Expands Its International Presence
WALTHAM, Mass.–(BUSINESS WIRE)–Fortis Life Sciences, a provider of high-quality reagents and custom services for discovery, development, and manufacturing, has expanded its international...
- 527Wire Stories
Philippines Buy Now Pay Later Business and Investment Opportunities Report 2022: BNPL Players are Raising Investment Rounds to Expand Their Loan Portfolio in the Philippines – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Philippines Buy Now Pay Later Business and Investment Opportunities – 75+ KPIs on Buy Now Pay Later Trends by End-Use...
